{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:10:40Z","timestamp":1770293440168,"version":"3.49.0"},"reference-count":116,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["opencardiovascularmedicinejournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOCMJ"],"published-print":{"date-parts":[[2022,9,5]]},"abstract":"<jats:p>Breast cancer is the most frequent malignant disease among women, being responsible for a considerable percentage of fatalities and comorbidities every year. Despite advances in early detection and therapy, evidence shows that breast cancer survivors are at increased risk of developing other chronic conditions, such as cardiovascular diseases.<\/jats:p>\n        <jats:p>Autonomic dysfunction is an emerging, but poorly understood topic that has been suggested as a risk factor for cardiovascular disease in breast cancer patients. It clinically manifests through persistently elevated heart rates and abnormal heart rate variability, even before any signs of cardiovascular dysfunction appear. Since changes in the left ventricular ejection fraction only manifest when myocardial injury has already occurred, it has been hypothesized that autonomic dysfunction can constitute an early biomarker of cardiovascular impairment in breast cancer patients. <\/jats:p>\n        <jats:p>This review focuses on the direct and indirect effects of cancer and its treatment on the autonomic nervous system in breast cancer patients. We highlight the mechanisms potentially involved in cancer and antineoplastic therapy-related autonomic imbalance and review the potential strategies to prevent and\/or attenuate autonomic dysfunction.<\/jats:p>\n        <jats:p>There are gaps in the current knowledge; more research in this area is needed to identify the relevance of autonomic dysfunction and define beneficial interventions to prevent cardiovascular disease in breast cancer patients.<\/jats:p>","DOI":"10.2174\/18741924-v16-e2206271","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:47:11Z","timestamp":1662356831000},"update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiovascular Dysautonomia in Patients with Breast Cancer"],"prefix":"10.2174","volume":"16","author":[{"given":"Vera","family":"Geraldes","sequence":"first","affiliation":[]},{"given":"Elisa","family":"Caldeira","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Machado","sequence":"additional","affiliation":[]},{"given":"\u00c2ngela","family":"Amaro-Leal","sequence":"additional","affiliation":[]},{"given":"Sergio","family":"Laranjo","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Rocha","sequence":"additional","affiliation":[]}],"member":"965","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","volume":"8","author":"Heer E.","year":"2020","unstructured":"Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. \n                    Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. \n                    Lancet Glob Health  \n                    2020; \n                    8\n                    (8)\n                    : e1027-37.","journal-title":"Lancet Glob. Health"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ahj.2015.05.014","volume":"170","author":"Lakoski S.G.","year":"2015","unstructured":"Lakoski SG, Jones LW, Krone RJ, Stein PK, Scott JM. \n                    Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms. \n                    Am Heart J  \n                    2015; \n                    170\n                    (2)\n                    : 231-41.","journal-title":"Am. Heart J."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1634\/theoncologist.2018-0049","volume":"24","author":"Kirkham A.A.","year":"2019","unstructured":"Kirkham AA, Lloyd MG, Claydon VE, Gelmon KA, McKenzie DC, Campbell KL. \n                    A longitudinal study of the association of clinical indices of cardiovascular autonomic function with breast cancer treatment and exercise training. \n                    Oncologist  \n                    2019; \n                    24\n                    (2)\n                    : 273-84.","journal-title":"Oncologist"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.15420\/cfr.2018.32.2","volume":"5","author":"Cuomo A.","year":"2019","unstructured":"Cuomo A, Rodolico A, Galdieri A, et al. \n                    Heart failure and cancer: Mechanisms of old and new cardiotoxic drugs in cancer patients. \n                    Card Fail Rev  \n                    2019; \n                    5\n                    (2)\n                    : 112-8.","journal-title":"Card. Fail. Rev."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1161\/CIR.0000000000000986","volume":"144","author":"Fradley M.G.","year":"2021","unstructured":"Fradley MG, Beckie TM, Brown SA, et al. \n                    Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology a scientific statement from the american heart association. \n                    Circulation  \n                    2021; \n                    144\n                    (3)\n                    : E41-55.","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12885-015-1418-3","volume":"15","author":"Adams S.C.","year":"2015","unstructured":"Adams SC, Schondorf R, Benoit J, Kilgour RD. \n                    Impact of cancer and chemotherapy on autonomic nervous system function and cardiovascular reactivity in young adults with cancer: a case-controlled feasibility study. \n                    BMC Cancer  \n                    2015; \n                    15\n                    (1)\n                    : 414.","journal-title":"BMC Cancer"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.121.054698","volume":"143","author":"Heck S.L.","year":"2021","unstructured":"Heck SL, Mecinaj A, Ree AH, et al. \n                    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (prada): extended follow-up of a 2\u00d72 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. \n                    Circulation  \n                    2021; \n                    143\n                    (25)\n                    : 2431-40.","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11739-020-02508-8","volume":"16","author":"Caspani F.","year":"2021","unstructured":"Caspani F, Tralongo AC, Campiotti L, Asteggiano R, Guasti L, Squizzato A. \n                    Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis. \n                    Intern Emerg Med  \n                    2021; \n                    16\n                    (2)\n                    : 477-86.","journal-title":"Intern. Emerg. Med."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.critrevonc.2020.103006","volume":"153","author":"Elghazawy H.","year":"2020","unstructured":"Elghazawy H, Venkatesulu BP, Verma V, et al. \n                    The role of cardio-protective agents in cardio-preservation in breast cancer patients receiving Anthracyclines \u00b1 Trastuzumab: a Meta-analysis of clinical studies. \n                    Crit Rev Oncol Hematol  \n                    2020; \n                    153\n                    : 103006.","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"100066","DOI":"10.1016\/j.esmoop.2021.100066","volume":"6","author":"Caparica R.","year":"2021","unstructured":"Caparica R, Bruzzone M, Agostinetto E, et al. \n                    Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis. \n                    ESMO Open  \n                    2021; \n                    6\n                    (2)\n                    : 100066.","journal-title":"ESMO Open"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02226960","volume":"13","author":"Martin R.","year":"1992","unstructured":"Martin R, Delgado JM, Molt\u00f2 JM, et al. \n                    Cardiovascular reflexes in patients with malignant disease. \n                    Ital J Neurol Sci  \n                    1992; \n                    13\n                    (2)\n                    : 125-9.","journal-title":"Ital. J. Neurol. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10286-018-0523-1","volume":"28","author":"Sim\u00f3 M.","year":"2018","unstructured":"Sim\u00f3 M, Navarro X, Yuste VJ, Bruna J. \n                    Autonomic nervous system and cancer. \n                    Clin Auton Res  \n                    2018; \n                    28\n                    (3)\n                    : 301-14.","journal-title":"Clin. Auton. Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e20424","DOI":"10.1371\/journal.pone.0020424","volume":"6","author":"M\u00fchlfeld C.","year":"2011","unstructured":"M\u00fchlfeld C, Das SK, Heinzel FR, et al. \n                    Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. \n                    PLoS One  \n                    2011; \n                    6\n                    (5)\n                    : e20424.","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.biopsycho.2005.11.013","volume":"74","author":"Thayer J.F.","year":"2007","unstructured":"Thayer JF, Lane RD. \n                    The role of vagal function in the risk for cardiovascular disease and mortality. \n                    Biol Psychol  \n                    2007; \n                    74\n                    (2)\n                    : 224-42.","journal-title":"Biol. Psychol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40959-020-00065-9","volume":"6","author":"Noor B.","year":"2020","unstructured":"Noor B, Akhavan S, Leuchter M, Yang EH, Ajijola OA. \n                    Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series. \n                    Cardiooncology  \n                    2020; \n                    6\n                    (1)\n                    : 11.","journal-title":"Cardiooncology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.cdp.2007.10.014","volume":"31","author":"Kovacic S.","year":"2007","unstructured":"Kovacic S, Lovrencic-Huzjan A, Drpa G, Hat J, Belina S. \n                    Horner\u2019s syndrome as an initial sign of metastatic breast cancer: Case report. \n                    Cancer Detect Prev  \n                    2007; \n                    31\n                    (6)\n                    : 450-2.","journal-title":"Cancer Detect. Prev."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jpainsymman.2009.06.014","volume":"39","author":"Fadul N.","year":"2010","unstructured":"Fadul N, Strasser F, Palmer JL, et al. \n                    The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. \n                    J Pain Symptom Manage  \n                    2010; \n                    39\n                    (2)\n                    : 283-90.","journal-title":"J. Pain Symptom Manage."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-684X-11-3","volume":"11","author":"Stone C.A.","year":"2012","unstructured":"Stone CA, Kenny RA, Nolan B, Lawlor PG. \n                    Autonomic dysfunction in patients with advanced cancer; prevalence, clinical correlates and challenges in assessment. \n                    BMC Palliat Care  \n                    2012; \n                    11\n                    (1)\n                    : 3.","journal-title":"BMC Palliat. Care"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00520-002-0376-x","volume":"10","author":"Walsh D.","year":"2002","unstructured":"Walsh D, Nelson KA. \n                    Autonomic nervous system dysfunction in advanced cancer. \n                    Support Care Cancer  \n                    2002; \n                    10\n                    (7)\n                    : 523-8.","journal-title":"Support. Care Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"14824","DOI":"10.1038\/s41598-020-71670-y","volume":"10","author":"McCallum G.A.","year":"2020","unstructured":"McCallum GA, Shiralkar J, Suciu D, et al. \n                    Chronic neural activity recorded within breast tumors. \n                    Sci Rep  \n                    2020; \n                    10\n                    (1)\n                    : 14824.","journal-title":"Sci. Rep."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10286-020-00724-y","volume":"31","author":"Kamiya A.","year":"2021","unstructured":"Kamiya A, Hiyama T, Fujimura A, Yoshikawa S. \n                    Sympathetic and parasympathetic innervation in cancer: therapeutic implications. \n                    Clin Auton Res  \n                    2021; \n                    31\n                    (2)\n                    : 165-78.","journal-title":"Clin. Auton. Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1001363","DOI":"10.1371\/journal.pbio.1001363","volume":"10","author":"Campbell J.P.","year":"2012","unstructured":"Campbell JP, Karolak MR, Ma Y, et al. \n                    Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. \n                    PLoS Biol  \n                    2012; \n                    10\n                    (7)\n                    : e1001363.","journal-title":"PLoS Biol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"Sloan E.K.","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, et al. \n                    The sympathetic nervous system induces a metastatic switch in primary breast cancer. \n                    Cancer Res  \n                    2010; \n                    70\n                    (18)\n                    : 7042-52.","journal-title":"Cancer Res."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41593-019-0430-3","volume":"22","author":"Kamiya A.","year":"2019","unstructured":"Kamiya A, Hayama Y, Kato S, et al. \n                    Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression. \n                    Nat Neurosci  \n                    2019; \n                    22\n                    (8)\n                    : 1289-305.","journal-title":"Nat. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/B978-0-444-52902-2.00041-2","volume":"115","author":"Koike H.","year":"2013","unstructured":"Koike H, Sobue G. \n                    Paraneoplastic neuropathy. \n                    Handb Clin Neurol  \n                    2013; \n                    115\n                    : 713-26.","journal-title":"Handb. Clin. Neurol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40164-016-0058-x","volume":"5","author":"Fanous I.","year":"2015","unstructured":"Fanous I, Dillon P. \n                    Paraneoplastic neurological complications of breast cancer. \n                    Exp Hematol Oncol  \n                    2015; \n                    5\n                    (1)\n                    : 29.","journal-title":"Exp. Hematol. Oncol."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Vernino S, Vincent A. \n                    Autoimmune and paraneoplastic autonomic neuropathies  \n                    \n                    2013; \n                    636-45.","DOI":"10.1093\/med\/9780198566342.003.0054"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/s-0035-1558983","volume":"35","author":"Dineen J.","year":"2015","unstructured":"Dineen J, Freeman R. \n                    Autonomic neuropathy. \n                    Semin Neurol  \n                    2015; \n                    35\n                    (4)\n                    : 458-68.","journal-title":"Semin. Neurol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10286-019-00611-1","volume":"29","author":"Golden E.P.","year":"2019","unstructured":"Golden EP, Vernino S. \n                    Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances. \n                    Clin Auton Res  \n                    2019; \n                    29\n                    (3)\n                    : 277-88.","journal-title":"Clin. Auton. Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/ijms20061451","volume":"20","author":"Zaj\u0105czkowska R.","year":"2019","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W, Wrzosek A, Mika J, Wordliczek J. \n                    Mechanisms of chemotherapy-induced peripheral neuropathy. \n                    Int J Mol Sci  \n                    2019; \n                    20\n                    (6)\n                    : 1451.","journal-title":"Int. J. Mol. Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11910-017-0757-7","volume":"17","author":"Cioroiu C.","year":"2017","unstructured":"Cioroiu C, Weimer LH. \n                    Update on Chemotherapy-Induced Peripheral Neuropathy. \n                    Curr Neurol Neurosci Rep  \n                    2017; \n                    17\n                    (6)\n                    : 47.","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e00558","DOI":"10.1002\/brb3.558","volume":"7","author":"Banach M.","year":"2017","unstructured":"Banach M, Juranek JK, Zygulska AL. \n                    Chemotherapy-induced neuropathies-a growing problem for patients and health care providers. \n                    Brain Behav  \n                    2017; \n                    7\n                    (1)\n                    : e00558.","journal-title":"Brain Behav."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000499599","volume":"14","author":"Jordan B.","year":"2019","unstructured":"Jordan B, Jahn F, Sauer S, Jordan K. \n                    Prevention and management of chemotherapy-induced polyneuropathy. \n                    Breast Care (Basel)  \n                    2019; \n                    14\n                    (2)\n                    : 79-84.","journal-title":"Breast Care (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/bja\/aex229","volume":"119","author":"Flatters S.J.L.","year":"2017","unstructured":"Flatters SJL, Dougherty PM, Colvin LA. \n                    Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. \n                    Br J Anaesth  \n                    2017; \n                    119\n                    (4)\n                    : 737-49.","journal-title":"Br. J. Anaesth."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11886-018-1010-y","volume":"20","author":"Coumbe B.G.T.","year":"2018","unstructured":"Coumbe BGT, Groarke JD. \n                    Cardiovascular Autonomic Dysfunction in Patients with Cancer. \n                    Curr Cardiol Rep  \n                    2018; \n                    20\n                    (8)\n                    : 69.","journal-title":"Curr. Cardiol. Rep."},{"key":"ref36","year":"2017","unstructured":"American Cancer Society. \n                   Chemotherapy for Breast Cancer | American Cancer Society. \n                   Am Cancer Soc \n                    2017.","journal-title":"Am Cancer Soc"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"Waks A.G.","year":"2019","unstructured":"Waks AG, Winer EP. \n                    Breast Cancer Treatment. \n                    JAMA  \n                    2019; \n                    321\n                    (3)\n                    : 288-300.","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Tonkin AL, Frewin DB. \n                    Drugs, chemicals, and toxins that alter autonomic function  \n                    \n                    2013; \n                    860-7.","DOI":"10.1093\/med\/9780198566342.003.0073"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","volume":"82","author":"Francis G.S.","year":"1990","unstructured":"Francis GS, Benedict C, Johnstone DE, et al. \n                    Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). \n                    Circulation  \n                    1990; \n                    82\n                    (5)\n                    : 1724-9.","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/CS20010102","volume":"101","author":"Nousiainen T.","year":"2001","unstructured":"Nousiainen T, Vanninen E, Jantunen E, et al. \n                    Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. \n                    Clin Sci (Lond)  \n                    2001; \n                    101\n                    (6)\n                    : 601-7.","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1634\/theoncologist.12-10-1156","volume":"12","author":"Jones L.W.","year":"2007","unstructured":"Jones LW, Haykowsky M, Pituskin EN, et al. \n                    Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer. \n                    Oncologist  \n                    2007; \n                    12\n                    (10)\n                    : 1156-64.","journal-title":"Oncologist"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1200\/JCO.2011.39.9014","volume":"30","author":"Jones L.W.","year":"2012","unstructured":"Jones LW, Courneya KS, Mackey JR, et al. \n                    Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. \n                    J Clin Oncol  \n                    2012; \n                    30\n                    (20)\n                    : 2530-7.","journal-title":"J. Clin. Oncol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.jacc.2008.01.038","volume":"51","author":"Lahiri M.K.","year":"2008","unstructured":"Lahiri MK, Kannankeril PJ, Goldberger JJ. \n                    Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. \n                    J Am Coll Cardiol  \n                    2008; \n                    51\n                    (18)\n                    : 1725-33.","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3332\/ecancer.2014.446","volume":"8","author":"Lenneman C.G.","year":"2014","unstructured":"Lenneman CG, Abdallah WM, Smith HM, et al. \n                    Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment? \n                    Ecancermedicalscience  \n                    2014; \n                    8\n                    : 446.","journal-title":"Ecancermedicalscience"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5935\/abc.20150075","volume":"105","author":"Guimar\u00e3es S.L.P de MM.","year":"2015","unstructured":"Guimar\u00e3es SLP de MM. \n                    Brand\u00e3o SCS, Andrade LR, Maia RJC, Markman Filho B. Hiperatividade simp\u00e1tica card\u00edaca ap\u00f3s quimioterapia: Sinal precoce de cardiotoxicidade? \n                    Arq Bras Cardiol  \n                    2015; \n                    105\n                    : 228-34.","journal-title":"Arq. Bras. Cardiol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jcpt.13258","volume":"46","author":"Feng Y.","year":"2021","unstructured":"Feng Y, Qin Z, Yang Z. \n                    Deceleration capacity of heart rate predicts trastuzumab related cardiotoxicity in patients with HER2 positive breast cancer: A prospective observational study. \n                    J Clin Pharm Ther  \n                    2021; \n                    46\n                    (1)\n                    : 93-8.","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1007\/s00520-019-05112-5","volume":"28","author":"Wu Y.","year":"2020","unstructured":"Wu Y, Wang Q, Zhang J, Cao J, Wang B, Hu X. \n                    Incidence of peripheral neuropathy associated with eribulin mesylate Versus vinorelbine in patients with metastatic breast cancer: sub-group analysis of a randomized phase III study. \n                    Support Care Cancer  \n                    2020; \n                    28\n                    (8)\n                    : 3819-29.","journal-title":"Support. Care Cancer"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.5935\/abc.20190036","volume":"112","author":"Gonzaga L.A.","year":"2019","unstructured":"Gonzaga LA, Paulo TRS, Viezel J, Vanzella LM, Freitas IF Jr, Vanderlei LCM. \n                    Changes in cardiac autonomic modulation in women with breast cancer using aromatase inhibitors and the relation with biochemical variables. \n                    Arq Bras Cardiol  \n                    2019; \n                    112\n                    (5)\n                    : 555-63.","journal-title":"Arq. Bras. Cardiol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","volume":"84","author":"Madsen M.L.","year":"2019","unstructured":"Madsen ML, Due H, Ejskj\u00e6r N, Jensen P, Madsen J, Dybk\u00e6r K. \n                    Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. \n                    Cancer Chemother Pharmacol  \n                    2019; \n                    84\n                    (3)\n                    : 471-85.","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s11764-015-0445-z","volume":"9","author":"Vigo C.","year":"2015","unstructured":"Vigo C, Gatzemeier W, Sala R, et al. \n                    Evidence of altered autonomic cardiac regulation in breast cancer survivors. \n                    J Cancer Surviv  \n                    2015; \n                    9\n                    (4)\n                    : 699-706.","journal-title":"J. Cancer Surviv."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40959-016-0019-x","volume":"2","author":"Schoormans D.","year":"2016","unstructured":"Schoormans D, Pedersen SS, Dalton S, Rottmann N, van de Poll-Franse L. \n                    Cardiovascular co-morbidity in cancer patients: the role of psychological distress. \n                    Cardiooncology  \n                    2016; \n                    2\n                    (1)\n                    : 9.","journal-title":"Cardiooncology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/onco.13528","volume":"26","author":"Nakamura Z.M.","year":"2021","unstructured":"Nakamura ZM, Deal AM, Nyrop KA, et al. \n                    Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer. \n                    Oncologist  \n                    2021; \n                    26\n                    (2)\n                    : 147-56.","journal-title":"Oncologist"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev-psych-062520-122331","volume":"72","author":"O\u2019Connor D.B.","year":"2021","unstructured":"O\u2019Connor DB, Thayer JF, Vedhara K. \n                    Stress and Health: A Review of Psychobiological Processes. \n                    Annu Rev Psychol  \n                    2021; \n                    72\n                    (1)\n                    : 663-88.","journal-title":"Annu. Rev. Psychol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00520-019-04834-w","volume":"28","author":"Fox R.S.","year":"2020","unstructured":"Fox RS, Ancoli-Israel S, Roesch SC, et al. \n                    Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. \n                    Support Care Cancer  \n                    2020; \n                    28\n                    (2)\n                    : 845-55.","journal-title":"Support. Care Cancer"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-019-05217-9","volume":"176","author":"Kreutz C.","year":"2019","unstructured":"Kreutz C, Schmidt ME, Steindorf K. \n                    Effects of physical and mind\u2013body exercise on sleep problems during and after breast cancer treatment: a systematic review and meta-analysis. \n                    Breast Cancer Res Treat  \n                    2019; \n                    176\n                    (1)\n                    : 1-15.","journal-title":"Breast Cancer Res. Treat."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.autneu.2019.01.009","volume":"217","author":"Baschieri F.","year":"2019","unstructured":"Baschieri F, Cortelli P. \n                    Circadian rhythms of cardiovascular autonomic function: Physiology and clinical implications in neurodegenerative diseases. \n                    Auton Neurosci  \n                    2019; \n                    217\n                    : 91-101.","journal-title":"Auton. Neurosci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.autneu.2019.02.006","volume":"218","author":"Silvani A.","year":"2019","unstructured":"Silvani A. \n                    Sleep disorders, nocturnal blood pressure, and cardiovascular risk: A translational perspective. \n                    Auton Neurosci  \n                    2019; \n                    218\n                    : 31-42.","journal-title":"Auton. Neurosci."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12282-019-00975-2","volume":"26","author":"Jones L.M.","year":"2019","unstructured":"Jones LM, Stoner L, Brown C, Baldi JC, McLaren B. \n                    Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion. \n                    Breast Cancer  \n                    2019; \n                    26\n                    (6)\n                    : 729-37.","journal-title":"Breast Cancer"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neubiorev.2008.05.024","volume":"33","author":"Davy K.P.","year":"2009","unstructured":"Davy KP, Orr JS. \n                    Sympathetic nervous system behavior in human obesity. \n                    Neurosci Biobehav Rev  \n                    2009; \n                    33\n                    (2)\n                    : 116-24.","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/02640414.2017.1356025","volume":"36","author":"Lahart I.M.","year":"2018","unstructured":"Lahart IM, Carmichael AR, Nevill AM, Kitas GD, Metsios GS. \n                    The effects of a home-based physical activity intervention on cardiorespiratory fitness in breast cancer survivors; a randomised controlled trial. \n                    J Sports Sci  \n                    2018; \n                    36\n                    (10)\n                    : 1077-86.","journal-title":"J. Sports Sci."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1249\/MSS.0000000000001970","volume":"51","author":"Foulkes S.J.","year":"2019","unstructured":"Foulkes SJ, Howden EJ, Bigaran A, et al. \n                    Persistent impairment in cardiopulmonary fitness after breast cancer chemotherapy. \n                    Med Sci Sports Exerc  \n                    2019; \n                    51\n                    (8)\n                    : 1573-81.","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"599","DOI":"10.12965\/jer.1735048.524","volume":"13","author":"Mostarda C.","year":"2017","unstructured":"Mostarda C, Castro-Filha J, Reis AD, et al. \n                    Short-term combined exercise training improves cardiorespiratory fitness and autonomic modulation in cancer patients receiving adjuvant therapy. \n                    J Exerc Rehabil  \n                    2017; \n                    13\n                    (5)\n                    : 599-607.","journal-title":"J. Exerc. Rehabil."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/2047487318811181","volume":"26","author":"Howden E.J.","year":"2019","unstructured":"Howden EJ, Bigaran A, Beaudry R, et al. \n                    Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. \n                    Eur J Prev Cardiol  \n                    2019; \n                    26\n                    (3)\n                    : 305-15.","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.3390\/cancers12082240","volume":"12","author":"Maginador G.","year":"2020","unstructured":"Maginador G, Lixandr\u00e3o ME, Bortolozo HI, et al. \n                    Aerobic exercise-induced changes in cardiorespiratory fitness in breast cancer patients receiving chemotherapy: A systematic review and meta-analysis. \n                    Cancers (Basel)  \n                    2020; \n                    12\n                    (8)\n                    : 2240.","journal-title":"Cancers (Basel)"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.ijcard.2013.11.113","volume":"171","author":"Scott J.M.","year":"2014","unstructured":"Scott JM, Jones LW, Hornsby WE, et al. \n                    Cancer therapy-induced autonomic dysfunction in early breast cancer: Implications for aerobic exercise training. \n                    Int J Cardiol  \n                    2014; \n                    171\n                    (2)\n                    : e50-1.","journal-title":"Int. J. Cardiol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41413-021-00137-1","volume":"9","author":"Concei\u00e7\u00e3o F.","year":"2021","unstructured":"Concei\u00e7\u00e3o F, Sousa DM, Paredes J, Lamghari M. \n                    Sympathetic activity in breast cancer and metastasis: partners in crime. \n                    Bone Res  \n                    2021; \n                    9\n                    (1)\n                    : 9.","journal-title":"Bone Res."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/bph.14709","volume":"178","author":"Martin T.J.","year":"2021","unstructured":"Martin TJ, Johnson RW. \n                    Multiple actions of parathyroid hormone related protein in breast cancer bone metastasis. \n                    Br J Pharmacol  \n                    2021; \n                    178\n                    (9)\n                    : 1923-35.","journal-title":"Br. J. Pharmacol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14779072.2017.1307736","volume":"15","author":"Park C.S.","year":"2017","unstructured":"Park CS, Lee HY. \n                    Clinical utility of sympathetic blockade in cardiovascular disease management. \n                    Expert Rev Cardiovasc Ther  \n                    2017; \n                    15\n                    (4)\n                    : 277-88.","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biocel.2019.01.004","volume":"108","author":"de Lucia C.","year":"2019","unstructured":"de Lucia C, Piedepalumbo M, Paolisso G, Koch WJ. \n                    Sympathetic nervous system in age-related cardiovascular dysfunction: Pathophysiology and therapeutic perspective. \n                    Int J Biochem Cell Biol  \n                    2019; \n                    108\n                    : 29-33.","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-019-09901-2","volume":"26","author":"Grassi G.","year":"2021","unstructured":"Grassi G, Quarti-Trevano F, Esler MD. \n                    Sympathetic activation in congestive heart failure: an updated overview. \n                    Heart Fail Rev  \n                    2021; \n                    26\n                    (1)\n                    : 173-82.","journal-title":"Heart Fail. Rev."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"H1476","DOI":"10.1152\/ajpheart.00859.2014","volume":"308","author":"Golbidi S","year":"2015","unstructured":"Golbidi S, Frisbee JC, Laher IX. \n                    Chronic stress impacts the cardiovascular system: Animal models and clinical outcomes. \n                    Am J Physiol - Hear Circ Physiol  \n                    2015; \n                    308\n                    : H1476-98.","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","volume":"29","author":"Miller A.J.","year":"2019","unstructured":"Miller AJ, Arnold AC. \n                    The renin\u2013angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. \n                    Clin Auton Res  \n                    2019; \n                    29\n                    (2)\n                    : 231-43.","journal-title":"Clin. Auton. Res."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1245\/s10434-006-9049-1","volume":"14","author":"Maki A.","year":"2007","unstructured":"Maki A, Kono H, Gupta M, et al. \n                    Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. \n                    Ann Surg Oncol  \n                    2007; \n                    14\n                    (3)\n                    : 1182-90.","journal-title":"Ann. Surg. Oncol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nri2566","volume":"9","author":"Tracey K.J.","year":"2009","unstructured":"Tracey KJ. \n                    Reflex control of immunity. \n                    Nat Rev Immunol  \n                    2009; \n                    9\n                    (6)\n                    : 418-28.","journal-title":"Nat. Rev. Immunol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/CS20110299","volume":"122","author":"De Couck M.","year":"2012","unstructured":"De Couck M, Mravec B, Gidron Y. \n                    You may need the vagus nerve to understand pathophysiology and to treat diseases. \n                    Clin Sci (Lond)  \n                    2012; \n                    122\n                    (7)\n                    : 323-8.","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1046\/j.1365-2281.2001.00342.x","volume":"21","author":"Bettermann H.","year":"2001","unstructured":"Bettermann H, Kr\u00f6z M, Girke M, Heckmann C. \n                    Heart rate dynamics and cardiorespiratory coordination in diabetic and breast cancer patients. \n                    Clin Physiol  \n                    2001; \n                    21\n                    (4)\n                    : 411-20.","journal-title":"Clin. Physiol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"678428","DOI":"10.3389\/fphys.2021.678428","volume":"12","author":"Wu S.","year":"2021","unstructured":"Wu S, Chen M, Wang J, Shi B, Zhou Y. \n                    Association of short-term heart rate variability with breast tumor stage. \n                    Front Physiol  \n                    2021; \n                    12\n                    : 678428.","journal-title":"Front. Physiol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1007\/s00392-018-1264-9","volume":"107","author":"Arab C.","year":"2018","unstructured":"Arab C, Vanderlei LCM, da Silva Paiva L, et al. \n                    Cardiac autonomic modulation impairments in advanced breast cancer patients. \n                    Clin Res Cardiol  \n                    2018; \n                    107\n                    (10)\n                    : 924-36.","journal-title":"Clin. Res. Cardiol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/PSY.0000000000000167","volume":"77","author":"Giese-Davis J.","year":"2015","unstructured":"Giese-Davis J, Wilhelm FH, Tamagawa R, et al. \n                    Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation. \n                    Psychosom Med  \n                    2015; \n                    77\n                    (4)\n                    : 346-55.","journal-title":"Psychosom. Med."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"14460","DOI":"10.1038\/s41598-021-93713-8","volume":"11","author":"Escutia-Reyes D.","year":"2021","unstructured":"Escutia-Reyes D, de Jes\u00fas Gardu\u00f1o-Garc\u00eda J, Emilio-L\u00f3pez-Ch\u00e1vez G, et al. \n                    Differences in heart rate variability and body composition in breast cancer survivors and women without cancer. \n                    Sci Rep  \n                    2021; \n                    11\n                    (1)\n                    : 14460.","journal-title":"Sci. Rep."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"914","DOI":"10.5603\/KP.2018.0098","volume":"76","author":"Stachowiak P.","year":"2018","unstructured":"Stachowiak P, Milchert-Leszczy\u0144ska M, Falco M, et al. \n                    Heart rate variability during and after chemotherapy with anthracycline in patients with breast cancer. \n                    Kardiol Pol  \n                    2018; \n                    76\n                    (5)\n                    : 914-6.","journal-title":"Kardiol. Pol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"e5228","DOI":"10.1097\/MD.0000000000005228","volume":"95","author":"Sun F.","year":"2016","unstructured":"Sun F, Shi J, Geng C. \n                    Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes. \n                    Medicine (Baltimore)  \n                    2016; \n                    95\n                    (44)\n                    : e5228.","journal-title":"Medicine (Baltimore)"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijcard.2016.09.053","volume":"224","author":"Palma M.R.","year":"2016","unstructured":"Palma MR, Vanderlei LCM, Ribeiro FE, Mantovani AM, Christofaro DGD, Fregonesi CEPT. \n                    The relationship between post-operative time and cardiac autonomic modulation in breast cancer survivors. \n                    Int J Cardiol  \n                    2016; \n                    224\n                    : 360-5.","journal-title":"Int. J. Cardiol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.ejca.2015.08.011","volume":"51","author":"de Azambuja E.","year":"2015","unstructured":"de Azambuja E, Ameye L, Diaz M, et al. \n                    Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy. \n                    Eur J Cancer  \n                    2015; \n                    51\n                    (17)\n                    : 2517-24.","journal-title":"Eur. J. Cancer"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/1055-9965.EPI-06-0870","volume":"16","author":"Jones L.W.","year":"2007","unstructured":"Jones LW, Haykowsky M, Peddle CJ, et al. \n                    Cardiovascular risk profile of patients with HER2\/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and\/or trastuzumab. \n                    Cancer Epidemiol Biomarkers Prev  \n                    2007; \n                    16\n                    (5)\n                    : 1026-31.","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"e997","DOI":"10.1161\/CIR.0000000000000679","volume":"139","author":"Gilchrist S.C.","year":"2019","unstructured":"Gilchrist SC, Barac A, Ades PA, et al. \n                    Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A scientific statement from the american heart association. \n                    Circulation  \n                    2019; \n                    139\n                    (21)\n                    : e997-e1012.","journal-title":"Circulation"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/09638288.2018.1514664","volume":"42","author":"Palma S.","year":"2020","unstructured":"Palma S, Keilani M, Hasenoehrl T, Crevenna R. \n                    Impact of supportive therapy modalities on heart rate variability in cancer patients \u2013 a systematic review. \n                    Disabil Rehabil  \n                    2020; \n                    42\n                    (1)\n                    : 36-43.","journal-title":"Disabil. Rehabil."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1055\/s-0032-1314816","volume":"34","author":"Niederer D.","year":"2012","unstructured":"Niederer D, Vogt L, Thiel C, et al. \n                    Exercise effects on HRV in cancer patients. \n                    Int J Sports Med  \n                    2012; \n                    34\n                    (1)\n                    : 68-73.","journal-title":"Int. J. Sports Med."},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1177\/1534735420969816","volume":"19","author":"Grote S.","year":"2020","unstructured":"Grote S, Ricci JM, Dehom S, Modeste N, Sealy DA, Tarleton HP. \n                    Heart rate variability and cardiovascular adaptations among cancer-survivors following a 26-week exercise intervention. \n                    Integr Cancer Ther  \n                    2020; \n                    19","journal-title":"Integr. Cancer Ther."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10741-017-9662-z","volume":"23","author":"Pearson M.J.","year":"2018","unstructured":"Pearson MJ, Smart NA. \n                    Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis. \n                    Heart Fail Rev  \n                    2018; \n                    23\n                    (1)\n                    : 91-108.","journal-title":"Heart Fail. Rev."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12885-020-07295-1","volume":"20","author":"Toohey K.","year":"2020","unstructured":"Toohey K, Pumpa K, McKune A, et al. \n                    The impact of high-intensity interval training exercise on breast cancer survivors: a pilot study to explore fitness, cardiac regulation and biomarkers of the stress systems. \n                    BMC Cancer  \n                    2020; \n                    20\n                    (1)\n                    : 787.","journal-title":"BMC Cancer"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"712823","DOI":"10.3389\/fpsyg.2021.712823","volume":"12","author":"Lav\u00edn-P\u00e9rez A.M.","year":"2021","unstructured":"Lav\u00edn-P\u00e9rez AM, Collado-Mateo D, Mayo X, Liguori G, Humphreys L, Jim\u00e9nez A. \n                    Can exercise reduce the autonomic dysfunction of patients with cancer and its survivors? A systematic review and meta-analysis. \n                    Front Psychol  \n                    2021; \n                    12\n                    : 712823.","journal-title":"Front. Psychol."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.clnu.2018.01.006","volume":"38","author":"Costa J.","year":"2019","unstructured":"Costa J, Moreira A, Moreira P, Delgado L, Silva D. \n                    Effects of weight changes in the autonomic nervous system: A systematic review and meta-analysis. \n                    Clin Nutr  \n                    2019; \n                    38\n                    (1)\n                    : 110-26.","journal-title":"Clin. Nutr."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00520-019-04817-x","volume":"28","author":"Chen S.C.","year":"2020","unstructured":"Chen SC, Yeh ML, Chang HJ, Lin MF. \n                    Music, heart rate variability, and symptom clusters: a comparative study. \n                    Support Care Cancer  \n                    2020; \n                    28\n                    (1)\n                    : 351-60.","journal-title":"Support. Care Cancer"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1196\/annals.1366.014","volume":"1088","author":"Thayer J.F.","year":"2006","unstructured":"Thayer JF, Sternberg E. \n                    Beyond heart rate variability: vagal regulation of allostatic systems. \n                    Ann N Y Acad Sci  \n                    2006; \n                    1088\n                    (1)\n                    : 361-72.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1534735411400311","volume":"10","author":"Chuang C.Y.","year":"2011","unstructured":"Chuang CY, Han WR, Li PC, Song MY, Young ST. \n                    Effect of long-term music therapy intervention on autonomic function in anthracycline-treated breast cancer patients. \n                    Integr Cancer Ther  \n                    2011; \n                    10\n                    (4)\n                    : 312-6.","journal-title":"Integr. Cancer Ther."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jjcc.2011.12.006","volume":"59","author":"Kishi T.","year":"2012","unstructured":"Kishi T. \n                    Heart failure as an autonomic nervous system dysfunction. \n                    J Cardiol  \n                    2012; \n                    59\n                    (2)\n                    : 117-22.","journal-title":"J. Cardiol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"487.e1","DOI":"10.1016\/j.ahj.2010.05.037","volume":"160","author":"Cadeddu C.","year":"2010","unstructured":"Cadeddu C, Piras A, Mantovani G, et al. \n                    Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment. \n                    Am Heart J  \n                    2010; \n                    160\n                    (3)\n                    : 487.e1-7.","journal-title":"Am. Heart J."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"Cardinale D.","year":"2006","unstructured":"Cardinale D, Colombo A, Sandri MT, et al. \n                    Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. \n                    Circulation  \n                    2006; \n                    114\n                    (23)\n                    : 2474-81.","journal-title":"Circulation"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","volume":"35","author":"MacFadyen R.","year":"1997","unstructured":"MacFadyen R, Barr CS, Struthers AD. \n                    Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. \n                    Cardiovasc Res  \n                    1997; \n                    35\n                    (1)\n                    : 30-4.","journal-title":"Cardiovasc. Res."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.196","volume":"17","author":"Akpek M.","year":"2015","unstructured":"Akpek M, Ozdogru I, Sahin O, et al. \n                    Protective effects of spironolactone against anthracycline-induced cardiomyopathy. \n                    Eur J Heart Fail  \n                    2015; \n                    17\n                    (1)\n                    : 81-9.","journal-title":"Eur. J. Heart Fail."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","volume":"73","author":"Guglin M.","year":"2019","unstructured":"Guglin M, Krischer J, Tamura R, et al. \n                    Randomized trial of lisinopril Versus carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer. \n                    J Am Coll Cardiol  \n                    2019; \n                    73\n                    (22)\n                    : 2859-68.","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/CRD.0000000000000252","volume":"27","author":"Blanter J.B.","year":"2019","unstructured":"Blanter JB, Frishman WH. \n                    The preventive role of angiotensin converting enzyme inhibitors\/angiotensin-II receptor blockers and \u03b2-adrenergic blockers in anthracycline- and trastuzumab-induced cardiotoxicity. \n                    Cardiol Rev  \n                    2019; \n                    27\n                    (5)\n                    : 256-9.","journal-title":"Cardiol. Rev."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e015327","DOI":"10.1161\/JAHA.119.015327","volume":"9","author":"Brown S.A.","year":"2020","unstructured":"Brown SA, Okwuosa TM, Barac A, Volgman AS. \n                    The Role of Angiotensin Converting Enzyme Inhibitors and \u03b2 Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. \n                    J Am Heart Assoc  \n                    2020; \n                    9\n                    (2)\n                    : e015327.","journal-title":"J. Am. Heart Assoc."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10741-019-09906-x","volume":"26","author":"Fang K.","year":"2021","unstructured":"Fang K, Zhang Y, Liu W, He C. \n                    Effects of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials. \n                    Heart Fail Rev  \n                    2021; \n                    26\n                    (1)\n                    : 101-9.","journal-title":"Heart Fail. Rev."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.breast.2017.10.010","volume":"37","author":"Gujral D.M.","year":"2018","unstructured":"Gujral DM, Lloyd G, Bhattacharyya S. \n                    Effect of prophylactic betablocker or ACE inhibitor on cardiac dysfunction & heart failure during anthracycline chemotherapy \u00b1 trastuzumab. \n                    Breast  \n                    2018; \n                    37\n                    : 64-71.","journal-title":"Breast"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000512848","volume":"146","author":"Lin H.","year":"2021","unstructured":"Lin H, Liang G, Wu Y, Chen L. \n                    Protective effects of ACEI\/ARB on left ventricular function in anthracycline-induced chronic cardiotoxicity: A meta-analysis of randomized controlled trials. \n                    Cardiology  \n                    2021; \n                    146\n                    (4)\n                    : 469-80.","journal-title":"Cardiology"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"ehaa946.3291","DOI":"10.1093\/ehjci\/ehaa946.3291","volume":"41","author":"Jeyaprakash P.","year":"2020","unstructured":"Jeyaprakash P, Sangha S, Robeldo K, et al. \n                    The role of cardio-protective agents in breast cancer patients to prevent anthracycline induced cardiotoxicity: a systematic review and network meta-analysis. \n                    Eur Heart J  \n                    2020; \n                    41\n                    (Suppl. 2)\n                    : ehaa946.3291.","journal-title":"Eur. Heart J."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jacc.2011.05.025","volume":"58","author":"Acar Z.","year":"2011","unstructured":"Acar Z, Kale A, Turgut M, et al. \n                    Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy. \n                    J Am Coll Cardiol  \n                    2011; \n                    58\n                    (9)\n                    : 988-9.","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","volume":"60","author":"Seicean S.","year":"2012","unstructured":"Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH. \n                    Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: An observational clinical cohort study. \n                    J Am Coll Cardiol  \n                    2012; \n                    60\n                    (23)\n                    : 2384-90.","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1074248418821721","volume":"24","author":"Nabati M.","year":"2019","unstructured":"Nabati M, Janbabai G, Esmailian J, Yazdani J. \n                    Effect of rosuvastatin in preventing chemotherapy-induced cardiotoxicity in women with breast cancer: A randomized, single-blind, placebo-controlled trial. \n                    J Cardiovasc Pharmacol Ther  \n                    2019; \n                    24\n                    (3)\n                    : 233-41.","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/FJC.0000000000000586","volume":"72","author":"El-Naggar A.E.","year":"2018","unstructured":"El-Naggar AE, El-Gowilly SM, Sharabi FM. \n                    Possible ameliorative effect of ivabradine on the autonomic and left ventricular dysfunction induced by doxorubicin in male rats. \n                    J Cardiovasc Pharmacol  \n                    2018; \n                    72\n                    (1)\n                    : 22-31.","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"549","DOI":"10.7150\/jca.6888","volume":"4","author":"Chae Y.K.","year":"2013","unstructured":"Chae YK, Brown EN, Lei X, et al. \n                    Use of ACE inhibitors and angiotensin receptor blockers and primary breast cancer outcomes. \n                    J Cancer  \n                    2013; \n                    4\n                    (7)\n                    : 549-56.","journal-title":"J. Cancer"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jchf.2015.05.008","volume":"3","author":"Chatterjee N.A.","year":"2015","unstructured":"Chatterjee NA, Singh JP. \n                    Novel interventional therapies to modulate the autonomic tone in heart failure. \n                    JACC Heart Fail  \n                    2015; \n                    3\n                    (10)\n                    : 786-802.","journal-title":"JACC Heart Fail."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1236787","volume":"2018","author":"De Couck M.","year":"2018","unstructured":"De Couck M, Caers R, Spiegel D, Gidron Y. \n                    The role of the vagus nerve in cancer prognosis: A systematic and a comprehensive review. \n                    J Oncol  \n                    2018; \n                    2018\n                    : 1-11.","journal-title":"J. Oncol."},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"De Couck M, Caers R. \n                    Why we should stimulate the vagus nerve in cancer open access symptom-cluster  \n                    2018; \n                    3","DOI":"10.1155\/2018\/1236787"}],"container-title":["The Open Cardiovascular Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V16\/e187419242206271\/e187419242206271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V16\/e187419242206271\/e187419242206271.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V16\/e187419242206271\/e187419242206271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:47:16Z","timestamp":1662356836000},"score":1,"resource":{"primary":{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/VOLUME\/16\/ELOCATOR\/e187419242206271\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,9,5]]}},"URL":"https:\/\/doi.org\/10.2174\/18741924-v16-e2206271","relation":{},"ISSN":["1874-1924"],"issn-type":[{"value":"1874-1924","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-2-2","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-3-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e187419242206271"}}